IVDs (in-vitro diagnostics) included in FDA's least burdensome guidance
This article was originally published in Clinica
Executive Summary
IVDs will be included in the FDA's upcoming guidance for agency reviewers on taking the least burdensome path to approving medical devices, the agency said last week.